While PGK1 is a well-characterized glycolytic enzyme with established links to tumor metabolism and hypoxia responses (21), MPHOSPH10 and MAP2K6 have received comparatively less attention in breast cancer. Here, MAP2K6 is linked to breast carcinoma.